Earnings Feed
Start Free
Home/Filings/4/0001739614-24-000021
4//SEC Filing

Deck Kelly 4

Accession 0001739614-24-000021

CIK 0001739614other
View on SEC.govCompany Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:36 PM ET

Size

12.3 KB

Accession

0001739614-24-000021

Insider Transaction Report

Form 4
Period: 2024-03-26
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-26$35.40/sh−416$14,726→ 9,167 total
    Exercise: $34.16Exp: 2032-01-11→ Common Stock (416 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-26$35.40/sh−396$14,018→ 17,624 total
    Exercise: $10.52Exp: 2028-11-26→ Common Stock (396 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-26$35.40/sh−1,459$51,649→ 14,583 total
    Exercise: $33.63Exp: 2031-01-15→ Common Stock (1,459 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-26$35.40/sh−625$22,125→ 21,250 total
    Exercise: $23.30Exp: 2033-01-03→ Common Stock (625 underlying)
Footnotes (4)
  • [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
  • [F2]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 11, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
  • [F3]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
  • [F4]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.

Documents

1 file

Issuer

Inhibrx, Inc.

CIK 0001739614

→
Entity typeother

Related Parties

1
  • filerCIK 0001819427

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:36 PM ET
Size
12.3 KB
View on SEC.gov